Maxx Farmacia (India) LLP
About Maxx Farmacia (India) LLP
Data last updated:
Maxx Farmacia (India) LLP is a limited liability partnership (LLP) based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 December 2014 and has been in existence for over 12 years.
The LLP is registered with the Registrar of Companies (ROC), Chennai, under LLPIN AAD-0524. Its GSTIN is 09ABAFM1336J1ZC (Uttar Pradesh). The LLP holds 10 GST registrations, of which 9 are active.
The LLP has a total obligation of contribution of ₹20 Lakh. It is led by designated partners Ayushi Srisrimal and Aayush Srisrimal.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2020, the LLP reported a revenue of ₹52.1 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹11.68 Lakh (net margin 0.2%) and EBITDA of ₹2.1 Cr (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 71% over three years.
The LLP has about 64 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹4 Cr and satisfied charges of ₹7.5 Cr on record. Court records list 15 cases involving the LLP, including 8 filed by the LLP and 7 filed against it; 13 cases are pending.
Company details
Contact details
Maxx Farmacia (India) LLP's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressNo.508 Inner Ring Road, Madhavaram, Chennai, Tamil Nadu, India – 600060
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maxx Farmacia (India) LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Maxx Farmacia (India) LLP
FY 2025 filings availableMaxx Farmacia (India) LLP reported revenue of ₹52.1 Cr (down 14% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 14% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 71%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | ₹52.1 Cr | ||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹11.68 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 0.2% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Maxx Farmacia (India) LLP, buy the company report.
Designated partners of Maxx Farmacia (India) LLP
Maxx Farmacia (India) has 2 current designated partners and 3 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ayushi Srisrimal | Designated Partner | 12 Nov 2025 | 0 Years 11 Months | Current |
| Aayush Srisrimal Also directs: Vital Wealth Catalyst and Logistics LLP, Worthwell Alpha LLP, Eco Sanitech LLP and 4 more | Designated Partner | 22 May 2018 | 8 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Aug 2021 | 100474294 | The Hongkong and Shanghai Banking Corporation Limited | ₹4 Cr | Open | |
| 24 Jul 2019 | 100299974 | Citi Bank N.A. | ₹4 Cr | Satisfied | |
| 16 Jan 2016 | 100015819 | Indian Overseas Bank | ₹3.5 Cr | Satisfied |
To see the full charge records of Maxx Farmacia (India) LLP, buy the company report.
Total charge records: 3 View all charges
Legal cases
Maxx Farmacia (India) LLP has 15 court cases on record: 8 filed by Maxx Farmacia (India), 7 filed against it. 13 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 1 | 9 |
| High courts | 6 | 6 | 4 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Cipla Health Limited & Anr. | Pending |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed against the company by Glaxosmithkline Pharmaceuticals Limited | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Glaxosmithkline Pharmaceuticals Limited | Pending |
| High Court of Delhi | Court case (CONT.CAS(C)) | Filed against the company by Sun Pharmaceutical Industries Ltd | Disposed |
| District court, Chennai, Tamil Nadu | Criminal case | Filed by the company against Jai Prithiviraj Prop Jai Maha Pharma Agenices | Pending |
To see the full case history of Maxx Farmacia (India) LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxx Farmacia (India) LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Maxx Farmacia (India) LLP has a workforce of 64 employees on its EPFO records as of Jun 29, 2024, across 1 active EPFO establishment.
GST
Maxx Farmacia (India) has 10 GST registrations: 9 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09ABAFM1336J1ZC | Uttar Pradesh | Active | 04 Jul 2017 |
| 06ABAFM1336J1ZI | Haryana | Active | 01 Aug 2020 |
| 27ABAFM1336J1ZE | Maharashtra | Active | 21 Sep 2020 |
| 23ABAFM1336J1ZM | Madhya Pradesh | Active | 02 Feb 2022 |
To see the full GST registrations and return filing status of Maxx Farmacia (India) LLP, buy the company report.
Recent activity
Maxx Farmacia (India) LLP has 5 designated partner changes on record since 2018: 2 appointments and 3 cessations. The latest: Ayushi Srisrimal was appointed as Designated Partner on 12 Nov 2025.
2 earlier events are in the company report.
Frequently asked questions
Maxx Farmacia (India) is an active limited liability partnership based in Chennai, Tamil Nadu, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 12 December 2014 (12+ years old) and is registered under LLPIN AAD-0524.
Maxx Farmacia (India) has 2 current designated partners:
- Ayushi Srisrimal - Designated Partner
- Aayush Srisrimal - Designated Partner
The latest financial statements of Maxx Farmacia (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Maxx Farmacia (India) is 09ABAFM1336J1ZC, registered in Uttar Pradesh. The LLP has 10 GST registrations in all, of which 9 are active and 1 is cancelled or inactive. Other active GSTINs include 06ABAFM1336J1ZI (Haryana), 27ABAFM1336J1ZE (Maharashtra), 23ABAFM1336J1ZM (Madhya Pradesh).
The LLPIN (Limited Liability Partnership Identification Number) of Maxx Farmacia (India) is AAD-0524. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Maxx Farmacia (India) has 15 court cases on record: 8 filed by the LLP and 7 filed against it. 13 are pending. Most are in the district courts.
Maxx Farmacia (India) was incorporated on 12 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chennai.
Ayushi Srisrimal was appointed as Designated Partner on 12 Nov 2025. Vinod Kumar Bansal ceased to be Designated Partner on 01 Apr 2021. Moti Lal Aggarwal ceased to be Designated Partner on 09 Jun 2020. Maxx Farmacia (India) has 5 designated partner changes on record in total.
The registered office of Maxx Farmacia (India) is at No.508 Inner Ring Road, Madhavaram, Chennai, Tamil Nadu, India – 600060.
Maxx Farmacia (India) operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
